Cargando…
Potential Utilization of APOBEC3-Mediated Mutagenesis for an HIV-1 Functional Cure
The introduction of combination antiretroviral therapy (cART) has managed to control the replication of human immunodeficiency virus type 1 (HIV-1) in infected patients. However, a complete HIV-1 cure, including a functional cure for or eradication of HIV-1, has yet to be achieved because of the per...
Autores principales: | Ikeda, Terumasa, Yue, Yuan, Shimizu, Ryo, Nasser, Hesham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239295/ https://www.ncbi.nlm.nih.gov/pubmed/34211449 http://dx.doi.org/10.3389/fmicb.2021.686357 |
Ejemplares similares
-
APOBEC3 degradation is the primary function of HIV-1 Vif for virus replication in the myeloid cell line THP-1
por: Ikeda, Terumasa, et al.
Publicado: (2023) -
APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1
por: Ikeda, Terumasa, et al.
Publicado: (2023) -
Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases
por: Koito, Atsushi, et al.
Publicado: (2013) -
Suppression of APOBEC3-mediated restriction of HIV-1 by Vif
por: Feng, Yuqing, et al.
Publicado: (2014) -
APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential
por: Butler, Kelly, et al.
Publicado: (2023)